EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Androgen receptor transcriptional activity is required for heregulin-1β–mediated nuclear localization of the HER3/ErbB3 receptor tyrosine kinase

Maitreyee K Jathal, Salma Siddiqui, Demitria M Vasilatis, Blythe P Durbin Johnson, Christiana Drake, Benjamin A Mooso, Leandro S D'Abronzo, Neelu Batra, Maria Mudryj, Paramita M Ghosh

Journal of Biological Chemistry · 2023

DOI: 10.1016/j.jbc.2023.104973 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023. Verfasst von Maitreyee K Jathal und 9 weiteren Autor:innen. Beteiligte Einrichtung: Research Service, VA Northern California Health Care System, Mather, California, USA; Department of Medical Microbiology and Immunology, University o…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant, Receptors, Androgen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, BLRD VA, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer is initially regulated by the androgen receptor (AR), a ligand-activated, transcription factor, and is in a hormone-dependent state (hormone-sensitive prostate cancer (HSPC)), but eventually becomes androgen-refractory (castration-resistant prostate cancer (CRPC)) because of mechanisms that bypass the AR, including by activation of ErbB3, a member of the epidermal growth factor receptor family. ErbB3 is synthesized in the cytoplasm and transported to the plasma membrane for ligand binding and dimerization, where it regulates downstream signaling, but nuclear forms are reported. Here, we demonstrate in prostatectomy samples that ErbB3 nuclear localization is observed in malignant, but not benign prostate, and that cytoplasmic (but not nuclear) ErbB3 correlated positively with AR expression but negatively with AR transcriptional activity. In support of the latter, androgen depletion upregulated cytoplasmic, but not nuclear ErbB3, while in vivo studies showed that castration suppressed ErbB3 nuclear localization in HSPC, but not CRPC tumors. In vitro treatment with the ErbB3 ligand heregulin-1β (HRG) induced ErbB3 nuclear localization, which was androgen-regulated in HSPC but not in CRPC. In turn, HRG upregulated AR transcriptional activity in CRPC but not in HSPC cells. Positive correlation between ErbB3 and AR expression was demonstrated in AR-null PC-3 cells where stable transfection of AR restored HRG-induced ErbB3 nuclear transport, while AR knockdown in LNCaP reduced cytoplasmic ErbB3. Mutations of ErbB3's kinase domain did not affect its localization but was responsible for cell viability in CRPC cells. Taken together, we conclude that AR expression regulated ErbB3 expression, its transcriptional activity suppressed ErbB3 nuclear translocation, and HRG binding to ErbB3 promoted it.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsProstatic Neoplasms, Castration-ResistantReceptors, AndrogenHumansMaleAndrogensCell Line, TumorLigandsNeuregulin-1Receptor Protein-Tyrosine KinasesReceptor, ErbB-3

Stichwörter der Autor:innen

ErbB3PSAandrogen receptorheregulin-1βprostate cancersubcellular localizationtranscription

Substanzen

AndrogensLigandsNeuregulin-1Receptor Protein-Tyrosine KinasesReceptors, AndrogenERBB3 protein, humanReceptor, ErbB-3

Autor:innen und Institutionen

  • Research Service, VA Northern California Health Care System, Mather, California, USA; Department of Medical Microbiology and Immunology, University of California Davis, Davis, California, USA.
  • Research Service, VA Northern California Health Care System, Mather, California, USA.
  • Research Service, VA Northern California Health Care System, Mather, California, USA; Department of Urologic Surgery, University of California Davis, Sacramento, California, USA.
  • Division of Biostatistics, Department of Public Health Sciences, University of California Davis, Davis, California, USA.
  • Department of Statistics, University of California Davis, Davis, California, USA.
  • Department of Urologic Surgery, University of California Davis, Sacramento, California, USA.

Förderung

  • NCI NIH HHS
  • BLRD VA
  • NIH HHS
  • Congressionally Directed Medical Research Programs
  • U.S. Department of Veterans Affairs
  • Department of Defense Prostate Cancer Research Program
  • National Institutes of Health
  • National Cancer Institute

Zitieren

APA

Jathal, M. K., Siddiqui, S., Vasilatis, D. M., Durbin Johnson, B. P., Drake, C., Mooso, B. A., D'Abronzo, L. S., Batra, N., Mudryj, M., & Ghosh, P. M. (2023). Androgen receptor transcriptional activity is required for heregulin-1β–mediated nuclear localization of the HER3/ErbB3 receptor tyrosine kinase. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.104973

Vancouver

Jathal MK, Siddiqui S, Vasilatis DM, Durbin Johnson BP, Drake C, Mooso BA, et al. Androgen receptor transcriptional activity is required for heregulin-1β–mediated nuclear localization of the HER3/ErbB3 receptor tyrosine kinase. Journal of Biological Chemistry. 2023. doi:10.1016/j.jbc.2023.104973

BibTeX
@article{Jathal2023,
  author = {Jathal, Maitreyee K and Siddiqui, Salma and Vasilatis, Demitria M and Durbin Johnson, Blythe P and Drake, Christiana and Mooso, Benjamin A and D'Abronzo, Leandro S and Batra, Neelu and Mudryj, Maria and Ghosh, Paramita M},
  title = {Androgen receptor transcriptional activity is required for heregulin-1β–mediated nuclear localization of the HER3/ErbB3 receptor tyrosine kinase},
  journal = {Journal of Biological Chemistry},
  year = {2023},
  doi = {10.1016/j.jbc.2023.104973}
}
Kostenlos starten →